NUCRYST appoints new Chairman & CEO

24-Aug-2007

The Board of Directors of NUCRYST Pharmaceuticals Corp. announced the appointment of Thomas E. Gardner as Chairman, President and Chief Executive Officer of the Company effective immediately. Mr. Gardner replaces Barry M. Heck as Chairman and Scott H. Gillis as President and Chief Executive Officer. Mr. Gillis is resigning his management and Board positions following eight years of leading NUCRYST to pursue new opportunities. Mr. Heck will remain as a director.

A director of NUCRYST since May 2007, Mr. Gardner specializes in the strategic positioning of companies with particular emphasis on pharmaceuticals, medical devices and healthcare information. Prior to his current assignments, Mr. Gardner was CEO of a number of public and private companies including: Songbird Hearing, Datamonitor, Base Ten Systems, and Access Health. From 1970 to 1995, Mr. Gardner held senior marketing and general management positions at Procter & Gamble, Johnson & Johnson, Simon & Schuster and IMS Health. He currently holds board seats at several privately held companies, including IntegriChain, VisiLED and Virium Pharmaceuticals.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances